Germany prostate cancer market is forecast to grow at a CAGR of 11.5% during the forecast period. The high prevalence of prostate cancer in the country is one of the major factors for the demand for prostate cancer diagnostics services and therapeutics. As per the World Health Organization, around 63,000 new cases of prostate cancer were registered in 2018. Cancer has the highest share of all cancer among men in the country with around 19% of the overall cases. The 5-year prevalence in the country due to prostate cancer is around 233,000 in 2018.